C$0.78 AIDX.TO Healwell AI Inc. TSX After Hours 27 Mar 2026: AI contracts shape outlook

AIDX.TO stock trades at C$0.78 after hours on 27 Mar 2026 as investors weigh record revenue and a new multi‑million dollar U.S. Health Information Exchange contract. The company reports year‑high C$1.77 and year‑low C$0.58, with volume 198,244 shares on the session. Healwell AI Inc. (AIDX.TO) is positioning its DARWEN™ AI engine across U.S., Canadian and Middle East customers, a growth driver analysts cite when modelling near‑term cash flows. We break down financials, technicals, Meyka AI grade and a short price forecast to frame risk and opportunity for AI stocks exposure

AIDX.TO stock: quick snapshot and key metrics

Healwell AI Inc. (AIDX.TO) trades on the TSX in Canada at C$0.78 with market cap C$228,791,563.00 and shares outstanding 293,322,517.00. Intraday range was C$0.75–C$0.78, 50‑day average C$0.80 and 200‑day average C$1.15. The company reports EPS -0.15 and a negative PE of -5.20, reflecting current losses as it scales AI products and recurring revenue

Company news, contracts and revenue momentum

Recent company releases show record fiscal 2025 revenue of approximately C$103.80 million, driven by SaaS and AI services and a multi‑year U.S. HIE contract. Management completed platform integration of Khure and Pentavere into DARWEN™ and is expanding deployments in the Middle East and U.S., supporting enterprise ARR growth. For primary sources see Reuters and a company summary at StockAnalysis source source

Financials and valuation: what the numbers say

Healwell shows improving top‑line growth but negative profitability and cash flow metrics; revenue per share TTM is C$0.40 while net income per share TTM is -C$0.16. Key ratios: price/sales 1.94, price/book 1.82, current ratio 0.91, debt/equity 0.69, EV/sales 2.52 and negative free cash flow per share -C$0.07. These figures point to revenue leverage but thin liquidity and elevated leverage compared with mature peers in Healthcare

Technicals and trading signals for an AI stocks play

Technical indicators show a neutral to mildly bearish setup: RSI 43.77, MACD histogram -0.01, ADX 29.09 suggesting a trending move, and Bollinger bands C$0.72–C$1.00. Average volume 552,374.00 over 50 days vs session volume 198,244.00 signals lighter trade today with relative liquidity risk for larger orders. Short‑term momentum is weak and some oscillators show oversold readings, so traders should monitor volume spikes around contract announcements

Meyka AI rates AIDX.TO with a score out of 100

Meyka AI rates AIDX.TO with a score out of 100: 61.65 (Grade B) – HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The model credits strong revenue growth but flags weaker cash conversion and negative margins. These grades are not guaranteed and we are not financial advisors

Risks and opportunities for AIDX.TO stock investors

Opportunity: enterprise AI contracts, record revenue and platform integrations can convert to higher ARR and margin expansion if retention holds. Risk: negative operating cash flow, current ratio below 1.00 and reliance on large contract wins create execution risk. Additional risk stems from sector volatility for Healthcare AI stocks and the company’s recent share concentration and average daily liquidity

Final Thoughts

Key takeaways for AIDX.TO stock investors: Healwell AI (AIDX.TO) trades at C$0.78 after hours on 27 Mar 2026, reflecting recent record revenue but continued negative EPS -0.15 and constrained cash flow. The company’s enterprise AI contracts and the DARWEN™ integration are positive drivers that support recurring revenue growth, yet valuation and liquidity metrics signal caution. Meyka AI’s forecast model projects a 3‑month target C$0.72 (implied downside -7.69%) and a 12‑month target C$0.40 (implied downside -48.77%) versus today’s price. Forecasts are model‑based projections and not guarantees. For investors seeking AI stocks exposure, AIDX.TO offers growth potential tied to contract execution but carries execution and liquidity risk; position sizing and active monitoring of contract updates and quarterly results are essential. Meyka AI provides this as AI‑powered market analysis for context and not investment advice

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.